NHO Kanazawa Medical Center

Kanazawa, Ishikawa-ken 9208650

1 studies enrolling now · 7 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), DDD, Dense Deposit Disease, IC-MPGN, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Membranoproliferative Glomerulonephritis, Membranoproliferative Glomerulonephritis (MPGN)

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Recruiting now
• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• ABTECT - Maintenance — Running, not enrolling
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• A Study of ALS-008176 in Infants Hospitalized With RSV — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed